Ilyang shares boosted by new leukemia drug

Shares of Ilyang Pharmaceutical Co., a Korean drug developer, were boosted on Monday by expectations that its new leukemia treatment may help lift earnings in the second half of this year, analyst said.

Ilyang shares rose 12 percent to 41,950 won in the morning of Monday on the Seoul bourse, showing a whopping 60 percent increase compared with 25,600 won on Dec. 1.

A newly-developed drug ...